Dr. Vinay P. Goswamy, MD

Dr. Goswamy practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Goswamy's NPI, 1356792022, was assigned on June 23, 2016. Dr. Goswamy holds California license A167886.

Dr. Goswamy's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Goswamy's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Goswamy to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goswamy practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Goswamy's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Goswamy is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Goswamy's licenses on file in 2 states: California and Wisconsin.

Dmand AI lists chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Goswamy treats.

CMS data shows 264 Medicare services from Dr. Goswamy across 5 procedure codes in 2024, for 137 Medicare patients. Medicare paid $24,618 for them.

CMS counts 137 Medicare patients who saw Dr. Goswamy in 2024. The largest group is 65 to 74, with 69 patients. 61% of them have high cholesterol, and 56% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goswamy's median patient age at 45, with 65% women.

In 2024, Dr. Goswamy wrote 625 Medicare Part D claims for 122 patients. 64% of them were for generic drugs. CMS names the drug for 518 of them, across 18 drugs with 11 or more claims each, at $206,077 in total drug cost. In 2023, CMS named 230 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Goswamy for performance year 2024, reported as part of a group. Dr. Goswamy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goswamy as offering telehealth.

Dmand AI links 4 papers to Dr. Goswamy, published from 2018 to 2024. Dr. Goswamy's most frequent co-authors are Ahmed S. Abuzaid, MD, Leonard B. Bacharier, MD and Ayman Elbadawi.

CMS Open Payments shows 2 general payments to Dr. Goswamy from 2 drug and device companies from 2018 to 2023. Education make up the largest share, 61% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $18.

Dr. Goswamy is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.